MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Differences in regional activity levels between healthy controls, PD-nFOG, and PD-FOG as measured by ALFF and fALFF using resting-state fMRI.

T. Davis, Z. Mari, V. Mishra (Birmingham, USA)

Meeting: 2024 International Congress

Abstract Number: 1080

Keywords: Functional magnetic resonance imaging(fMRI), Gait disorders: Pathophysiology

Category: Parkinson's Disease: Neuroimaging

Objective: To elucidate regional neural activity differences in patients with PD-FOG using resting-state fMRI (rs-fMRI).

Background: Freezing of gait (FOG) in Parkinson’s disease (PD0 is an issue with gait where those affected are unable to begin walking, turn, or move around in tight spaces. Little is known about why freezing of gait occurs, although one theory behind why FOG happens is an alteration in neural connectivity between certain areas of the brain. Neuronal activity causes low-frequency fluctuations of brain activity which can be measured by (ALFF) and its standardized counterpart, fractional ALFF (fALFF). We hypothesize that we will see decreased ALFF values and increased fALFF values in those with PD-FOG compared to PD-nFOG and HC.

Method: 8 patients with PD-FOG, 10 with PD-nFOG, and 11 healthy controls (HC) were recruited for this study. All subjects underwent rs-fMRI scans on a 3T Siemens Skyra scanner. The rs-fMRI involved gradient-echo T2*-weighted echo-planar imaging (EPI) acquisition (repetition time [TR] = 700 ms, echo time [TE] = 28.4 ms, flip angle = 42°, resolution = 2.3 × 2.3 × 2.3 mm3, 64 axial slices, multiband = 8). All BOLD data underwent preprocessing using fMRIB Software Library (FSL; https://fsl.fmrib.ox.ac.uk/fsl/fslwiki), Advanced Normalization Tools (ANTs; https://github.com/ANTsX/ANTs/wiki), and in-house MATLAB scripts. We obtained general demographics for all subjects and the disease duration, FOGQ score, levodopa equivalent doses (LEDD), physical therapy tests ([table 1]) , and MDS-UPDRS-III scores for each patient with PD. We collected neuropsychological tests scores for all participants ([table 1]).

Results: We found trending differences (p<0.05) in ALFF and fALFF between HC and PD-nFOG, HC and PD-FOG, and PD-nFOG and PD-FOG. Specifically, we found changes in ALFF values between HC and PD-nFOG in the frontoparietal and occipital regions and changes in ALFF between PD-nFOG and PD-FOG in the frontoparietal regions. We also found changes in fALFF values between HC and PD-FOG in the frontoparietal regions (not shown).

Conclusion: Our analysis concluded that there are differences in regional activity of areas involved in visuospatial perception and movements, which can be measured by ALFF and fALFF. Future analysis of the correlation with neuropsychological scores is underway.

zALFF maps

zALFF maps

Demographics

Demographics

To cite this abstract in AMA style:

T. Davis, Z. Mari, V. Mishra. Differences in regional activity levels between healthy controls, PD-nFOG, and PD-FOG as measured by ALFF and fALFF using resting-state fMRI. [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/differences-in-regional-activity-levels-between-healthy-controls-pd-nfog-and-pd-fog-as-measured-by-alff-and-falff-using-resting-state-fmri/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/differences-in-regional-activity-levels-between-healthy-controls-pd-nfog-and-pd-fog-as-measured-by-alff-and-falff-using-resting-state-fmri/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley